• Return to Headlines

SmarTrend Watching for Potential Rebound in Shares of Regeneron Pharmaceuticals After 2.23% Loss

By James Quinn

Regeneron Pharmaceuticals (NASDAQ:REGN) traded in a range yesterday that spanned from a low of $453.54 to a high of $470.28. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $461.58 on volume of 926,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

In the past 52 weeks, shares of Regeneron Pharmaceuticals have traded between a low of $42.83 and a high of $605.93 and are now at $458.77, which is 971% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.4% while the 200-day MA has slid 0.7%.

SmarTrend recommended that subscribers consider buying shares of Regeneron Pharmaceuticals on May 2nd, 2017 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $397.84. Since that recommendation, shares of Regeneron Pharmaceuticals have risen 18.0%. We continue to monitor REGN for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: rebounders regeneron pharmaceuticals

Ticker(s): REGN